CYP2D6

Cytochrome P450, family 2, subfamily D, polypeptide 6
	PDB基于2f9q的渲染图
有效结构
PDB	直系同源检索：PDBe, RCSB
PDB查询代码列表
	2F9Q, 3QM4, 3TBG, 3TDA, 4WNT, 4WNU, 4WNV, 4WNW
标识
代号	CYP2D6; CPD6; CYP2D; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; P450-DB1; P450C2D; P450DB1
扩展标识	遗传学：124030 鼠基因：1929474 同源基因：133550 GeneCards: CYP2D6 Gene
EC編號	1.14.14.1
基因本体论描述
分子功能	· monooxygenase activity; · iron ion binding; · drug binding; · arachidonic acid epoxygenase activity; · steroid hydroxylase activity; · oxidoreductase activity; · oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; · oxygen binding; · heme binding; · aromatase activity;
细胞成分	· cytoplasm; · mitochondrion; · endoplasmic reticulum; · endoplasmic reticulum membrane;
生物过程	· xenobiotic metabolic process; · steroid metabolic process; · coumarin metabolic process; · alkaloid metabolic process; · alkaloid catabolic process; · monoterpenoid metabolic process; · drug metabolic process; · arachidonic acid metabolic process; · isoquinoline alkaloid metabolic process; · drug catabolic process; · exogenous drug catabolic process; · small molecule metabolic process; · heterocycle metabolic process; · negative regulation of binding; · oxidation-reduction process; · oxidative demethylation; · negative regulation of cellular organofluorine metabolic process;
	Sources: Amigo / QuickGO
RNA表达模式
	更多表达数据
直系同源体
	查; 论; 编;

细胞色素 P450 2D6（cytochrome P450 2D6，CYP2D6）是一种由人类CYP2D6基因编码的酶。CYP2D6主要合成而显现于肝脏，并且也表现在中枢神经系统中，包括黑质。

CYP2D6是细胞色素P450混合功能氧化酶系统的成员之一，是人体中最重要的代谢酶之一。CYP2D6参与25%的临床药物的代谢和清除，过程主要是O-去甲基化。^[1]CYP2D6也参与多种内源性物质的代谢，如5-羟色胺和神经类固醇。^[1]

引用[编辑]

^ ^1.0 ^1.1 Wang B, Yang LP, Zhang XZ, Huang SQ, Bartlam M, Zhou SF. New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme. Drug Metab. Rev. 2009, 41 (4): 573–643. PMID 19645588. doi:10.1080/03602530903118729.

延伸閱讀[编辑]

Smith G, Stubbins MJ, Harries LW, Wolf CR. Molecular genetics of the human cytochrome P450 monooxygenase superfamily. Xenobiotica. 1998, 28 (12): 1129–65. PMID 9890157. doi:10.1080/004982598238868.
Wolf CR, Smith G. Cytochrome P450 CYP2D6. IARC Sci. Publ. 1999, (148): 209–29. PMID 10493260.
Ding X, Kaminsky LS. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 2003, 43 (1): 149–73. PMID 12171978. doi:10.1146/annurev.pharmtox.43.100901.140251.
Lilienfeld S. Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. CNS Drug Rev. 2002, 8 (2): 159–76. PMID 12177686. doi:10.1111/j.1527-3458.2002.tb00221.x.
Yu AM, Idle JR, Gonzalez FJ. Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates. Drug Metab. Rev. 2004, 36 (2): 243–77. PMID 15237854. doi:10.1081/DMR-120034000.
Abraham JE, Maranian MJ, Driver KE, Platte R, Kalmyrzaev B, Baynes C, Luccarini C, Shah M, Ingle S, Greenberg D, Earl HM, Dunning AM, Pharoah PD, Caldas C. CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen. Breast Cancer Res. 2010, 12 (4): R64. PMC 2949659 . PMID 20731819. doi:10.1186/bcr2629.
Abraham JE, Maranian MJ, Driver KE, Platte R, Kalmyrzaev B, Baynes C, Luccarini C, Earl HM, Dunning AM, Pharoah PD, Caldas C. CYP2D6 gene variants and their association with breast cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 2011, 20 (6): 1255–8. PMID 21527579. doi:10.1158/1055-9965.EPI-11-0321.

外部連結[编辑]

[pmid19645588-1] 1.0 ^1.1 Wang B, Yang LP, Zhang XZ, Huang SQ, Bartlam M, Zhou SF. New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme. Drug Metab. Rev. 2009, 41 (4): 573–643. PMID 19645588. doi:10.1080/03602530903118729.

[1]